110 related articles for article (PubMed ID: 9609897)
41. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
42. Correlation between the severity of hepatitis B cirrhosis and CT volumetry-based hepatic segmental anatomic changes.
Apisarnthanarak P; Wongsawaeng D; Muangsomboon K
J Med Assoc Thai; 2014 Aug; 97(8):856-62. PubMed ID: 25345262
[TBL] [Abstract][Full Text] [Related]
43. Semi-quantitative assessment of the presence and Child-Pugh class of hepatitis B related cirrhosis by using liver lobe-based dynamic contrast-enhanced MRI.
Zhou L; Wang LY; Zhang XM; Zeng NL; Chen TW; Li R; Huang YC; Tang YL
Clin Radiol; 2016 Dec; 71(12):1289-1295. PubMed ID: 27633724
[TBL] [Abstract][Full Text] [Related]
44. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
[TBL] [Abstract][Full Text] [Related]
45. Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients.
Gouya H; Vignaux O; Sogni P; Mallet V; Oudjit A; Pol S; Legmann P
Radiology; 2011 Oct; 261(1):144-55. PubMed ID: 21771955
[TBL] [Abstract][Full Text] [Related]
46. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
[TBL] [Abstract][Full Text] [Related]
47. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
48. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.
Sangiovanni A; Prati GM; Fasani P; Ronchi G; Romeo R; Manini M; Del Ninno E; Morabito A; Colombo M
Hepatology; 2006 Jun; 43(6):1303-10. PubMed ID: 16729298
[TBL] [Abstract][Full Text] [Related]
49. [Gamna-Gandy bodies in cirrhosis: a meaningless finding?].
Laurent O; Lubrano J; de Beauregard M; Aubry S; Kastler B; Delabrousse É
J Radiol; 2011 Oct; 92(10):909-14. PubMed ID: 22000612
[TBL] [Abstract][Full Text] [Related]
50. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
Tu XL; Xiao YQ; Chen F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
[TBL] [Abstract][Full Text] [Related]
51. Magnetic resonance imaging in chronic liver disease evaluated in relation to hepatic fibrosis--clinical and experimental results.
Ohno A; Ohta Y; Ohtomo K; Hirata K; Takatsuki K; Mochida S; Ogata I; Itai Y; Iio M; Fujiwara K
Radiat Med; 1990; 8(5):159-63. PubMed ID: 2075231
[TBL] [Abstract][Full Text] [Related]
52. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.
Kim JY; Lee SS; Byun JH; Kim SY; Park SH; Shin YM; Lee MG
AJR Am J Roentgenol; 2013 Aug; 201(2):322-31. PubMed ID: 23883212
[TBL] [Abstract][Full Text] [Related]
53. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
54. [Assessment of disease activity and liver fibrosis in chronic viral hepatitis by magnetic resonance diffusion-weighted imaging].
Yang Y; Song B; Wu B; Lei XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):155-9. PubMed ID: 19507592
[TBL] [Abstract][Full Text] [Related]
55. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
[TBL] [Abstract][Full Text] [Related]
56. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
[TBL] [Abstract][Full Text] [Related]
57. Liver fibrosis and chronic viral hepatitis.
Gutierrez-Reyes G; Gutierrez-Ruiz MC; Kershenobich D
Arch Med Res; 2007 Aug; 38(6):644-51. PubMed ID: 17613356
[TBL] [Abstract][Full Text] [Related]
58. Quantification of superparamagnetic iron oxide-mediated signal intensity change in patients with liver cirrhosis using T2 and T2* mapping: a preliminary report.
Chung YE; Park MS; Kim MS; Kim E; Park J; Song HT; Choi JY; Kim MJ; Kim KW
J Magn Reson Imaging; 2010 Jun; 31(6):1379-86. PubMed ID: 20512890
[TBL] [Abstract][Full Text] [Related]
59. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
